For the quarter ending 2025-09-30, MMSI had $50,646K increase in cash & cash equivalents over the period. $52,542K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 27,755 | 62,728 |
| Depreciation and amortization | 31,316 | 60,313 |
| Gain on disposition of business | 0 | 249 |
| Loss on sale or abandonment of property and equipment | -231 | -315 |
| Write-off of certain intangible assets and other long-term assets | 70 | 82 |
| Amortization of right-of-use operating lease assets | 2,927 | 5,766 |
| Fair value adjustments related to contingent consideration liabilities | 32 | 1,166 |
| Amortization of deferred credits | 25 | 52 |
| Amortization and write-off of long-term debt issuance costs | 1,414 | 2,828 |
| Stock-based compensation expense | 13,612 | 19,951 |
| Trade receivables | 6,346 | 7,310 |
| Other receivables | 701 | -2,817 |
| Inventories | 3,353 | 11,720 |
| Prepaid expenses and other current assets | 463 | 2,575 |
| Income tax refund receivables | -3,513 | 3,653 |
| Other assets | 358 | 1,471 |
| Trade payables | -269 | 3,697 |
| Accrued expenses | 7,589 | -2,740 |
| Income taxes payable | 1,948 | 1,537 |
| Deferred compensation payable | -2,717 | 603 |
| Operating lease liabilities | -2,653 | -5,925 |
| Other long-term obligations | 1,460 | -2,229 |
| Total adjustments | 47,227 | 61,151 |
| Net cash, cash equivalents, and restricted cash provided by operating activities | 74,982 | 123,879 |
| Property and equipment | 22,440 | 34,812 |
| Intangible assets | 1,031 | 1,296 |
| Proceeds from the sale of property and equipment | 4 | 45 |
| Proceeds from disposition of business | 0 | 249 |
| Cash paid for notes receivable and other investments | 319 | 14,617 |
| Cash paid in acquisitions, net of cash acquired | 279 | 122,555 |
| Net cash, cash equivalents, and restricted cash used in investing activities | -24,065 | -172,986 |
| Proceeds from issuance of common stock | 2,165 | 20,014 |
| Contingent payments related to acquisitions | 78 | 2,567 |
| Payment of taxes related to an exchange of common stock | 2,452 | 6,145 |
| Net cash, cash equivalents, and restricted cash provided by (used in) financing activities | -365 | 11,302 |
| Effect of exchange rates on cash, cash equivalents, and restricted cash | 94 | 2,953 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | 50,646 | -34,852 |
| Cash and cash equivalents at beginning of period | 378,767 | - |
| Cash and cash equivalents at end of period | 394,561 | - |
MERIT MEDICAL SYSTEMS INC (MMSI)
MERIT MEDICAL SYSTEMS INC (MMSI)